Challenges and Opportunities in the France Prostate Cancer Drugs Market
The France prostate cancer therapeutics market size is expected to grow at a CAGR of around 12.01% from 2024 to 2035. In France, prostate cancer is still a paramount public health concern. It is the most frequently diagnosed cancer in men and makes up about one-quarter of male cancer cases. Nearly 60,000 new cases are diagnosed annually, and over 9,200 deaths were recorded in 2022. It...
0 Comments 0 Shares 68 Views 0 Reviews